HomeCompareCUTR vs GBDC

CUTR vs GBDC: Dividend Comparison 2026

CUTR yields 2063.98% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CUTR wins by $13331039286.37M in total portfolio value
10 years
CUTR
CUTR
● Live price
2063.98%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13331039307.22M
Annual income
$12,171,036,297,947,368.00
Full CUTR calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — CUTR vs GBDC

📍 CUTR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCUTRGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CUTR + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CUTR pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CUTR
Annual income on $10K today (after 15% tax)
$175,438.60/yr
After 10yr DRIP, annual income (after tax)
$10,345,380,853,255,262.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, CUTR beats the other by $10,345,380,839,272,138.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CUTR + GBDC for your $10,000?

CUTR: 50%GBDC: 50%
100% GBDC50/50100% CUTR
Portfolio after 10yr
$6665519664.03M
Annual income
$6,085,518,157,199,051.00/yr
Blended yield
91.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CUTR
Analyst Ratings
4
Buy
5
Hold
Consensus: Hold
Price Target
$39.25
+40405.7% upside vs current
Range: $1.00 — $68.00
Altman Z
-2.8
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CUTR buys
0
GBDC buys
0
No recent congressional trades found for CUTR or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCUTRGBDC
Forward yield2063.98%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$13331039307.22M$20.85M
Annual income after 10y$12,171,036,297,947,368.00$16,450,733.83
Total dividends collected$13248903950.40M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy
Analyst price target$39.25$14.00

Year-by-year: CUTR vs GBDC ($10,000, DRIP)

YearCUTR PortfolioCUTR Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$217,098$206,398.35$12,492$1,791.70+$204.6KCUTR
2$4,420,028$4,187,732.78$16,527$3,160.58+$4.40MCUTR
3$84,412,065$79,682,634.57$23,588$5,904.90+$84.39MCUTR
4$1,512,516,762$1,422,195,852.90$37,141$11,901.65+$1512.48MCUTR
5$25,434,529,072$23,816,136,137.07$66,205$26,463.38+$25434.46MCUTR
6$401,507,365,308$374,292,419,200.69$137,452$66,612.65+$401507.23MCUTR
7$5,951,621,357,208$5,522,008,476,328.59$342,372$195,298.53+$5951621.01MCUTR
8$82,867,113,366,068$76,498,878,513,854.90$1,053,292$686,954.33+$82867112.31MCUTR
9$1,084,114,961,932,747$995,447,150,631,054.80$4,111,439$2,984,416.95+$1084114957.82MCUTR
10$13,331,039,307,215,410$12,171,036,297,947,368.00$20,849,974$16,450,733.83+$13331039286.37MCUTR

CUTR vs GBDC: Complete Analysis 2026

CUTRStock

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Full CUTR Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CUTR vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CUTR vs SCHDCUTR vs JEPICUTR vs OCUTR vs KOCUTR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.